GLP-1 RA use is associated with a lower risk of developing Parkinson disease compared with sulfonylurea use in a large cohort study.
Dopamine agonists are medications that mimic the effects of dopamine, which can be helpful if you have low dopamine levels. Dopamine is a complex and key neurotransmitter responsible for many of our ...
Among adults with obesity, the risk for new physician-reported sleep apnea and new-onset obstructive sleep apnea ...
Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with patients ...
A recent study in Nature Immunology by Dr. Alfred Singer and colleagues demonstrate how T cells develop through a complex process known as agonist signaling. This novel study helps establish ...
This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...
In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a glucagon/GLP-1 receptor dual agonist1The trial met both weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results